The introduction of the drug in the country is creating significant interest within the medical community. This novel dual compound – acting on both GLP-1 and GIP targets – presents a potentially effective approach https://australianpeptidestore.co/retatrutide-value-bundle-starter-kit-research-peptide-australian-peptide-store/